Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Effect of a Multidisciplinary Intervention on Fatigue in Lymphoma Survivors With Persistent Fatigue: A Randomized Controlled Trial (the REFUEL trial).

Created on 21 Nov 2026

Authors

Synne-Kristin H Bøhn, Tone Skaali, Torbjørn Wisløff, Cecilie E Kiserud, Alexander Fosså, Mette Seland, Unn-Merete Fagerli, Kristin V Reinertsen, Rune Blomhoff, Kerry S Courneya, Elisabeth Edvardsen, Gunhild M Gjerset, Hege B Henriksen, Hanne C Lie, Jon Håvard Loge, Tormod S Nilsen, Line Merethe Oldervoll, Truls Raastad, Corina S Rueegg, Arkady Rutkovskiy, Torkil Berge, Elin Fjerstad, Gro Sandberg, Malene Slott, Linn Viktil, Lene Thorsen

Published in

Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Pages JCO2600414. Nov 20, 2026. Epub Nov 20, 2026.

Abstract

Persistent fatigue is a prevalent, complex, and distressing late effect among lymphoma survivors. We examined the effect of a multidisciplinary intervention on fatigue among lymphoma survivors with persistent fatigue.
Lymphoma survivors with persistent fatigue (moderate to severe fatigue ≥6 months) were randomly assigned to usual care (n = 75) or a 12-week multidisciplinary intervention (n = 75). The intervention consisted of patient education, physical exercise, a cognitive-behavioral therapy-based program, and nutritional counseling. Total fatigue was assessed by the Chalder Fatigue Questionnaire (range, 0-33) 3 months after random assignment (T1; primary outcome) and at 6 (T2) and 9 (T3) months after random assignment (secondary outcomes). Other secondary outcomes were functioning and global health status/quality of life (QoL) assessed by European Organisation for Research and Treatment of Cancer QoL Questionnaire-C30. Effects were analyzed with baseline-adjusted linear mixed models for repeated measures.
Compared with usual care, the intervention group reported significantly lower total fatigue at T1 (between-group difference [BGD], -3.5 [95% CI, -5.4 to -1.6]; P < .001). Secondary outcome analyses indicated that total fatigue remained lower in the intervention group at T2 (BGD, -2.4 [95% CI, -4.4 to -0.5]), but not at T3 (BGD, -0.9 [95% CI, -3.0 to 1.2]). At T1, secondary outcome analyses indicated positive intervention effects on physical (BGD, 3.8 [95% CI, 0.2 to 7.3]) and role functioning (BGD, 9.2 [95% CI, 0.9 to 17.5]) and global health status/QoL (BGD, 9.5 [95% CI, 3.5 to 15.4]), but not on social (BGD, -0.1 [95% CI, -7.4 to 7.3]), emotional (BGD, 5.6 [95% CI, 0.0 to 11.3]), or cognitive functioning (BGD, 3.5 [95% CI, -3.3 to 10.2]).
A multidisciplinary intervention improved fatigue among lymphoma survivors with persistent fatigue. The effect appeared to be maintained 6 months after random assignment but dissipated at 9 months.

PMID:
43063370
Bibliographic data and abstract were imported from PubMed on 21 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement